~~<i id='D0BCF14F8A'><strike id='D0BCF14F8A'><tt id='D0BCF14F8A'><pre id='D0BCF14F8A'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

author：entertainment 2025-10-03 00:19:57 Page View：2946

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： RaDonda Vaught links Vanderbilt hospital issues to patient death
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

Wikipedia

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

HHS secretary Becerra pressed on Change HealthCare cyberattack

HealthandHumanServicesSecretaryXavierBecerratestifiesThursdayduringaSenateFinanceCommitteehearingonP

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

1:00MontanaRepublicancandidateforSenateTimSheehy.TimSheehyCampaignThewebsiteofthecompanyrunbyMontana